INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine

PLYMOUTH MEETING, Pa., April 6, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the U.S. Food and Drug Administration has accepted the company ' s Investigational New Drug (IND) application for INO-4800, its...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials